Yan's study found that compared with patients with HBV+ cirrhosis, patients with HBV+HCC had a significantly lower proportion of CD3+ and CD8+ T cells and an increased proportion of Tregs in their peripheral blood, which means that HBV+HCC exhibits a stronger immune‐suppressive response. This evidence concerns the gene CD8A and Cirrhosis.